G. Hynes (Oxford (Oxfordshire), United Kingdom), S. Kazani (Cambridge , United States of America), P. Wark (New Lambton Heights (NSW), Australia), C. Bal (Wien, Austria)
The prevalence and clinical characteristics of T2-high and T2-low endotype of severe uncontrolled asthma distinguished by combining popular type-2 biomarkers
K. Oishi (Ube, Japan), T. Hirano (Ube, Japan), K. Matsuda (Ube, Japan), K. Hamada (Ube, Japan), S. Uehara (Ube, Japan), R. Suetake (Ube, Japan), Y. Yamaji (Ube, Japan), M. Asami-Noyama (Ube, Japan), N. Edakuni (Ube, Japan), K. Matsunaga (Ube, Japan)
|   |
The prevalence of subtypes of type-2 inflammation in a real-life population of patients with difficult-to-control asthma
L. Frøssing (Copenhagen, Denmark), A. Von Bülow (Copenhagen, Denmark), V. Backer (Copenhagen, Denmark), C. Porsbjerg (Copenhagen, Denmark)
| |
The German Severe Asthma Registry and Type 2-high and Type 2-low asthma phenotypes
S. Korn (Mainz, Germany), A. Koch (Friedberg, Germany), C. Schulz (Regensburg, Germany), M. Gappa (Wesel, Germany), H. Timmermann (Hamburg, Germany), R. Ehmann (Stuttgart, Germany), M. Schuhmann (Heidelberg, Germany), E. Hamelmann (Bielefeld, Germany), R. Buhl (Mainz, Germany)
| |
The Impact of Current Smoking on Severe Asthma in the Wessex Severe Asthma Cohort
J. Gates (Portsmouth, United Kingdom), T. Brown (Portsmouth, United Kingdom), T. Jones (Portsmouth, United Kingdom), S. Elliott (Portsmouth, United Kingdom), K. Gove (Southampton, United Kingdom), C. Barber (Southampton, United Kingdom), A. Chauhan (Portsmouth, United Kingdom), P. Howarth (Southampton, United Kingdom)
| |
Dupilimab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Asthma by Body Mass Index
S. Korn (Mainz, Germany), W. Busse (Madison, United States of America), J. Echave-Sustaeta (Madrid, Spain), A. Dixon (Burlington, United States of America), J. Mucsi (Gödöllö, Hungary), M. Rice (Cambridge, United States of America), Y. Deniz (Tarrytown, United States of America), P. Rowe (Bridgewater, United States of America), H. Staudinger (Bridgewater, United States of America), N. Amin (Tarrytown, United States of America), M. Ruddy (Tarrytown, United States of America), N. Graham (Tarrytown, United States of America), A. Teper (Bridgewater, United States of America)
| |
Physical activity pattern of severe asthmatic patients treated with biological therapy.
G. Scioscia (Foggia, Italy), G. Messina (Foggia, Italy), D. Lacedonia (Foggia, Italy), F. Sessa (Foggia, Italy), M. Foschino Barbaro (Foggia, Italy), G. Lepore (Foggia, Italy), C. Quarato (Foggia, Italy), M. Venuti (Foggia, Italy), A. Depalo (Foggia, Italy), C. Colanardi (Foggia, Italy), G. Carpagnano (Foggia, Italy)
| |
Diagnostic value of combined sIgG and sIgE of Aspergillus fumigatus in allergic broncho pulmonary aspergillosis and severe asthma with fungal sensitation
H. Hu (Guangzhou, China), B. Sun (Guangzhou, China), H. Huang (Guangzhou, China)
| |
Cost analysis for patients with severe asthma receiving omalizumab treatment
H. Ates (Ankara, Turkey), K. Aksu (Ankara, Turkey), Ö. Özdedeoglu (Ankara, Turkey), B. Basa Akdogan (Ankara, Turkey), I. Koca Kalkan (Ankara, Turkey), G. Köycü Buhari (Ankara, Turkey), F. Öner Erkekol (Ankara, Turkey)
| |
EVALUATION OF THE IMMUNOGLOBULIN G LEVEL AND THE GAMMAGLOBULIN FRACTION OF THE PROTEINOGRAM IN THE COPD EXACERBATOR PHENOTYPE
J. Juanola Pla (Mataró, Spain), R. Boixeda Viu (Mataró, Spain), I. Moreno Hernandez (Vilassar de Dalt, Spain), M. Bartolomé Regue (Mataró, Spain), M. Garcia Caballero (Mataró, Spain), A. Duran Molina (Mataró, Spain), M. Perez Godia (Mataró, Spain), E. Palomera Fanegas (Mataró, Spain), M. Serra-Prat (Mataró, Spain), J. Almirall Pujol (Mataró, Spain)
| |
The relationship between frailty and Patient-Reported Outcomes in elderly patients with stable asthma
M. Kusunose (Obu, Aichi, Japan), R. Sanda (Obu, Aichi, Japan), A. Narita (Obu, Aichi, Japan), K. Nishimura (Obu, Aichi, Japan)
| |
New view at the problem of COPD with bronchial asthma (A)
A. Babenko (Dnipro, Ukraine), T. Pertseva (Dnipro, Ukraine), L. Konopkina (Dnipro, Ukraine), L. Botvinikova (Dnipro, Ukraine), O. Myronenko (Dnipro, Ukraine)
| |
Microbiological features of the indicators of bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD) during remission
M. Smirnova-Saprytskaya (??????, Russian Federation), G. Osipova (??????, Russian Federation), T. Ospelnikova (??????, Russian Federation), G. Danilina (??????, Russian Federation), K. Zykov (??????, Russian Federation)
| |
Roles of sensitization to staphylococcus enterotoxin in patients with obstructive lung diseases
C. Morimoto (Kyoto, Japan), H. Matsumoto (Kyoto, Japan), S. Sato (Kyoto, Japan), T. Oguma (Kyoto, Japan), A. Sato (Kyoto, Japan), N. Tashima (Kyoto, Japan), Y. Ishiyama (Kyoto, Japan), H. Sunadome (Kyoto, Japan), T. Nagasaki (Kyoto, Japan), I. Ito (Kyoto, Japan), S. Muro (Kashihara, Japan), T. Hirai (Kyoto, Japan)
| |
Microbiome landscape and disease duration role in allergy in adult patients with bronchiectasis
K. Gashynova (Dnipro, Ukraine), K. Suska (Dnipro, Ukraine), V. Dmytrychenko (Dnipro, Ukraine)
| |
Bronchiectasis and aspergillus-associated diseases in severe asthma
P. Solidoro (Turin, Italy), F. De Blasio (Turin, Italy), D. Dassetto (Turin, Italy), R. Ambrosanio (Turin, Italy), A. Rella (Turin, Italy), L. Riberi (Turin, Italy), C. Bucca (Turin, Italy)
| |
Increased relative levels of IgG subclasses, mainly IgG3, in patient with bronchiectasis and history of exacerbations; preliminary results from a single tertiary center.
P. Ghosh (Stockholm, Sweden), I. Gerhardson (Stockholm, Sweden), B. Dahlen (Stockholm, Sweden), A. Bossios (Stockholm, Sweden)
| |
Peripheral blood eosinophilia and sensitization to Aspergillus fumigatus in adult patients (pts) with non-cystic fibrosis bronchiectasis (B)
K. Gashynova (Dnipro, Ukraine), V. Dmytrychenko (Dnipro, Ukraine), K. Suska (Dnipro, Ukraine)
| |
Bronchial inflammation, respiratory symptoms and lung function in patients who finished treatment for pulmonary tuberculosis: is it the beginning of a new disease?
I. Palma (Buenos Aires, Argentina), L. Castro Zorrilla (Buenos Aires, Argentina), A. Resguardo (Buenos Aires, Argentina), D. Martinez (Buenos Aires, Argentina), D. Troncoso (Buenos Aires, Argentina), V. Cruz (Buenos Aires, Argentina), J. Vina (Buenos Aires, Argentina), L. Alves (Buenos Aires, Argentina), M. Natiello (Buenos Aires, Argentina), R. Estevan (Buenos Aires, Argentina), N. Lazari (Buenos Aires, Argentina), M. Medin (Buenos Aires, Argentina), S. Inwentarz (Buenos Aires, Argentina), A. Videla (Buenos Aires, Argentina), D. Palmero (Buenos Aires, Argentina)
| |
Relationship between atopy, asthma and alpha-1 antitrypsin deficiency
M. Aiello (Parma, Italy), A. Fantin (Parma, Italy), A. Frizzelli (Parma, Italy), C. Longo (Parma, Italy), M. Negri (Parma, Italy), F. Bonatti (Parma, Italy), A. Percesepe (Parma, Italy), G. Bertorelli (Parma, Italy), E. Crisafulli (Parma, Italy), I. Ferrarotti (Pavia, Italy), R. Pisi (Parma, Italy), A. Chetta (Parma, Italy)
| |